The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback